MASLD Often Is Worse in Slim Patients MASLD Often Is Worse in Slim Patients

Among patients with metabolic dysfunction-associated steatotic liver disease, the rate of advanced fibrosis is more than twice as high in slim patients than in patients with overweight or obesity.Medscape Medical News
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Gastroenterology Source Type: news